Traditional risk factors may not explain increased incidence of myocardial infarction in MS
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To compare the risk of incident acute myocardial infarction (AMI) in the multiple sclerosis (MS) population and a matched population without MS, controlling for traditional vascular risk factors.
Methods We conducted a retrospective matched cohort study using population-based administrative (health claims) data in 2 Canadian provinces, British Columbia and Manitoba. We identified incident MS cases using a validated case definition. For each case, we identified up to 5 controls without MS matched on age, sex, and region. We compared the incidence of AMI between cohorts using incidence rate ratios (IRR). We used Cox proportional hazards regression to compare the hazard of AMI between cohorts adjusting for sociodemographic factors, diabetes, hypertension, and hyperlipidemia. We pooled the provincial findings using meta-analysis.
Results We identified 14,565 persons with MS and 72,825 matched controls. The crude incidence of AMI per 100,000 population was 146.2 (95% confidence interval [CI] 129.0–163.5) in the MS population and 128.8 (95% CI 121.8–135.8) in the matched population. After age standardization, the incidence of AMI was higher in the MS population than in the matched population (IRR 1.18; 95% CI 1.03–1.36). After adjustment, the hazard of AMI was 60% higher in the MS population than in the matched population (hazard ratio 1.63; 95% CI 1.43–1.87).
Conclusion The risk of AMI is elevated in MS, and this risk may not be accounted for by traditional vascular risk factors.
Glossary
- AMI=
- acute myocardial infarction;
- BC=
- British Columbia;
- CI=
- confidence interval;
- COPD=
- chronic obstructive pulmonary disease;
- DAD=
- Discharge Abstract Database;
- DIN=
- drug identification number;
- DMT=
- disease-modifying therapy;
- ICD=
- International Classification of Diseases;
- ICD-9-CM=
- International Classification of Diseases–9–clinical modification;
- ICD-10-CA=
- International Classification of Diseases–10-Canada;
- HR=
- hazard ratio;
- IHD=
- ischemic heart disease;
- IRR=
- incidence rate ratio;
- MS=
- multiple sclerosis;
- SES=
- socioeconomic status
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received July 27, 2018.
- Accepted in final form November 27, 2018.
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Sex differences in comorbidity at diagnosis of multiple sclerosisA population-based studyRuth Ann Marrie, Scott B. Patten, Helen Tremlett et al.Neurology, March 09, 2016 -
Article
Cancer Incidence and Mortality Rates in Multiple SclerosisA Matched Cohort StudyRuth Ann Marrie, Colleen Maxwell, Alyson Mahar et al.Neurology, November 25, 2020 -
Article
Comorbidity increases the risk of hospitalizations in multiple sclerosisRuth Ann Marrie, Lawrence Elliott, James Marriott et al.Neurology, December 24, 2014 -
Article
Effect of comorbidity on mortality in multiple sclerosisRuth Ann Marrie, Lawrence Elliott, James Marriott et al.Neurology, May 27, 2015